Related Experiment Video
Updated: Aug 30, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Fulminant Eosinophilic Myocarditis in Steroid-Refractory Hypereosinophilic Syndrome: Navigating the Thrombotic Stage
Mutaz Althobaiti1, Dhai Aldlgan2, Lama Alfehaid3
1King Abdulaziz Cardiac Center (KACC), Riyadh, Saudi Arabia; King Abdulaziz Medical City (KAMC), Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.
Background:
Hypereosinophilic syndrome is a rare hematologic disorder with multiorgan involvement. Its most lethal form, Loeffler endomyocarditis, often results in fatal cardiac or embolic events.
Case Summary:
A 57-year-old woman presented with chest pain, an absolute eosinophil count of 42 × 109/L, and a peak troponin of 47,000 ng/L. She developed acute encephalopathy from a cardioembolic storm and eosinophilic pleocytosis. Although echocardiography was inconclusive, cardiac magnetic resonance (CMR) identified a large laminar thrombus and subendocardial necrosis. Despite pulse-dose steroids and hydroxyurea, she suffered a hematologic relapse. Initiation of mepolizumab (anti-interleukin-5) led to rapid eosinophil normalization and clinical recovery.
Discussion:
This case highlights the diagnostic superiority of CMR over echocardiography for detecting laminar thrombi. It illustrates the limitations of steroids in suppressing the myeloproliferative drive and demonstrates mepolizumab's efficacy as an acute rescue therapy.
Take-Home Messages:
CMR is mandatory in suspected eosinophilic myocarditis when echocardiography is negative. In steroid-refractory hypereosinophilic syndrome, early interleukin-5 inhibition is a life-saving intervention.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care